Phase III Trial Evaluating the Addition of Bevacizumab to Letrozole As First-line Endocrine Therapy for Treatment of Hormone-receptor Positive Advanced Breast Cancer: CALGB 40503 (Alliance)
      Google Scholar   
Citation:
J. Clin. Oncol. vol 33 (suppl) abstr 501
Meeting Instance:
ASCO 2015
Year:
2015
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Parents:
None
Children:
42   2434  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA31946, CA180888, CA180858, CA180820, CA180785  
Corr. Author:
 
Authors:
                             
Networks:
ADM400, ADM402, ADM403, ALLIANCE, CA011, CA043, CA136, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-TX035, NY018, TX041   
Study
CALGB-40503
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: